HomeNUNZ • OTCMKTS
add
Nunzia Pharmaceutical Corp
Previous close
$0.00
Market cap
430.00 USD
Avg Volume
17.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2021info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 78.06M | 198,391.90% |
Net income | -78.06M | 22.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2021info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.00 | — |
Total assets | 5.13K | — |
Total liabilities | 99.30K | 67.17% |
Total equity | -94.17K | — |
Shares outstanding | 434.12M | — |
Price to book | ∞ | — |
Return on assets | — | — |
Return on capital | 431,791.03% | — |
Cash Flow
Net change in cash
| (USD) | 2021info | Y/Y change |
|---|---|---|
Net income | -78.06M | 22.72% |
Cash from operations | -86.78K | -168.71% |
Cash from investing | — | — |
Cash from financing | 86.91K | 169.11% |
Net change in cash | 131.00 | — |
Free cash flow | — | — |
About
Founded
1986
Headquarters
Website
Employees
4
